メドパシーの株は 期待に圧倒されても 52週低減しました Medpace's stock hit a 52-week low despite beating earnings expectations.

臨床開発サービスの提供者であるMedpaceは,その株価が274.02ドルで,月曜日に277.05ドルで閉店する前に,52週間の新低値に達した. Medpace, a provider of clinical development services, saw its stock hit a new 52-week low at $274.02 before closing at $277.05 on Monday. 最近の"保留"評価及び平均価格目標368. 30. にもかかわらず,同社は3.67 EPSで収益の期待を打破し,同社は2.96ドルを突破した. Despite a recent "Hold" rating and an average price target of $368.30, the company beat earnings expectations with $3.67 EPS, up from a consensus of $2.96. メドパシーの株は,459.77ドルと269.36ドルの低い52週の高値との間で変動している. Medpace's stock has fluctuated between a 52-week high of $459.77 and a low of $269.36.